Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-001472

Chief Operating Officer sold 20,000 shares at $11.98 ($239,600)

  • Chief Operating Officer acquired 210,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
GIVEN BRUCE D Chief Operating Officer 2019-01-01 Grant or award +210,000 1,118,356 D: show line 1 in the form
GIVEN BRUCE D Chief Operating Officer 2019-01-02 Sale −20,000 $11.98 $239,600 1,098,356 D: show line 2 in the form
Open-market sales · 20,000 sh · avg $11.98 · $239,600
Loading xslF345X03/doc4.xml…